Apptly Announces $1,000,000 Non-Brokered Private Placement
ICEsoft Releases Q2 2026 Financial Results
SATO Technologies Corp. Announces Loan Settlement Eliminating All of Its Senior Secured Debt and C$1.5 Million Private Placement
Theralase(R) Closes C$3.6 Million Brokered Financing
DelphX Provides Update to Closing of Private Placements
CHICAGO–(BUSINESS WIRE)–The AZEK Company Inc. (NYSE: AZEK) (“AZEK” or the “Company”), the industry-leading manufacturer of…
Company announcement – No. 36 / 2023 Total number of shares and voting rights in…
HARTLAND, Wis.–(BUSINESS WIRE)–Fathom Digital Manufacturing Corp. (“Fathom” or the “Company”) (NYSE: FATH), an industry leader…
Divestment includes Xiidra®, on-market treatment for dry eye disease and additional ophthalmic investigational therapies Novartis…
Proof-of-concept data supports the clinical evaluation of the Cell Pouch System as a potential treatment…
The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing…
Toronto, Ontario–(Newsfile Corp. – September 29, 2023) – Deveron Corp. (TSXV: FARM) is pleased to…
BROOKLYN HEIGHTS, Ohio–(BUSINESS WIRE)–GrafTech International Ltd. (NYSE:EAF) (“GrafTech” or the “Company”) announced today that Marcel…
Company Appoints Ed Grabscheid as new CFO, Jacob Shulman to depart as CFO at Fiscal…
NEWCASTLE & HOUSTON–(BUSINESS WIRE)–TechnipFMC (NYSE: FTI) has been awarded a significant(1) contract to supply flexible…
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today…
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage…